Varicella-zoster virus thymidine kinase. Characterization and substrate specificity
G B Roberts1, J A Fyfe, S A McKee
1Wellcome Research Laboratories, Research Triangle Park, NC 27709.
Biochemical Pharmacology
|December 14, 1993
Summary
The varicella-zoster virus (VZV) thymidine kinase (TK) enzyme efficiently phosphorylates anti-VZV nucleosides. Bacterially expressed VZV TK exhibits substrate specificities similar to the native enzyme, crucial for antiviral drug development.
Area of Science:
- Biochemistry
- Virology
- Enzymology
Background:
- The varicella-zoster virus (VZV) thymidine kinase (TK) is a key enzyme in viral replication.
- VZV TK phosphorylates nucleoside analogs, activating them as antiviral agents.
- Understanding VZV TK's substrate specificity is vital for designing effective anti-VZV therapies.
Purpose of the Study:
- To characterize bacterially expressed VZV thymidine kinase (TK).
- To determine the enzyme's kinetic properties, substrate specificity, and inhibition patterns.
- To compare the properties of bacterially expressed VZV TK with the native enzyme.
Main Methods:
- Purification and characterization of bacterially expressed VZV TK.
- Kinetic analysis of thymidine phosphorylation using varying MgATP concentrations.
- Determination of substrate and inhibitor specificities, including nucleoside and nucleotide interactions.
- Comparison of enzyme properties with VZV TK purified from infected cells.
Main Results:
- Bacterially expressed VZV TK showed kinetic properties consistent with a two-site model for MgATP binding.
- The enzyme's phosphate donor and acceptor specificities were identical to native VZV TK.
- Detailed nucleoside specificity studies revealed preferential phosphorylation of thymine 2'-deoxyribonucleosides, followed by other pyrimidines and purines.
- dTTP acted as a noncompetitive inhibitor of thymidine phosphorylation but competed with MgATP.
Conclusions:
- Bacterially expressed VZV TK accurately reflects the properties of the native viral enzyme.
- The characterized substrate specificities provide a basis for rational drug design against VZV.
- Understanding VZV TK inhibition by dTTP can inform the development of antiviral strategies.
Related Concept Videos
Chickenpox
Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


